VG Acquisition Corp. (VGAC) to Combine with 23andMe in $3.5Bn Deal
VG Acquisition Corp. (NYSE:VGAC) has entered a definitive agreement to combine with 23andMe for an enterprise value of $3.46 billion. 23andMe provides consumers information about their ancestry and gene-based health factors through DNA tests and has leveraged its platform for broader genetic research. The combined entity is expected to trade on the NYSE under theRead More